Statizoid

Health in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)

493 indicators covering health for Middle East, North Africa, Afghanistan & Pakistan (excluding high income).

IndicatorLatest Year10-yr change Rank
Maternal mortality ratio 131 2023 down 24.7% 19th
Number of maternal deaths, per capita 0 units per person 2023 down 35.5% 18th
Number of maternal deaths, per unit of GDP 0 units per US$ of GDP 2023 down 29.2% 15th
Number of maternal deaths, per square kilometre 0.0023 units per square kilometre 2023 down 23.3% 20th
Number of maternal deaths, annual growth rate -4.17 % change on previous year 2023 down 29.2% 20th
Probability of dying among adolescents ages 10-19 years 6.89 per 1,000 2024 down 16.1% 17th
Probability of dying among children ages 5-9 years, female 2.51 per 1,000 2024 down 25.0% 17th
Probability of dying among children ages 5-9 years, male 3.13 per 1,000 2024 down 22.3% 16th
Probability of dying among adolescents ages 10-14 years, female 2.22 per 1,000 2024 down 16.8% 17th
Probability of dying among adolescents ages 10-14 years, male 3.09 per 1,000 2024 down 14.3% 15th
Probability of dying among adolescents ages 10-19 years, female 5.17 per 1,000 2024 down 15.1% 19th
Probability of dying among adolescents ages 10-19 years, male 8.51 per 1,000 2024 down 16.8% 16th
Probability of dying among adolescents ages 15-19 years, female 2.97 per 1,000 2024 down 12.5% 20th
Probability of dying among adolescents ages 15-19 years, male 5.45 per 1,000 2024 down 17.2% 19th
Probability of dying among youth ages 20-24 years, female 3.26 per 1,000 2024 down 4.5% 23rd
Probability of dying among youth ages 20-24 years, male 8 per 1,000 2024 down 15.3% 21st
Women's share of population ages 15+ living with HIV 33.2% 2024 up 0.4% 16th
Prevalence of HIV, female 0.1% 2024 down 0.2% 19th
Prevalence of HIV, male 0.1% 2024 down 0.2% 20th
Prevalence of overweight, female 64.6% 2022 up 15.1% 9th
Prevalence of overweight, male 55.1% 2022 up 20.8% 17th
Prevalence of overweight 59.9% 2022 up 17.8% 12th
Immunization, HepB3 83.7% 2024 up 6.4% 27th
Newborns protected against tetanus 84.1% 2024 up 5.0% 13th
Population ages 00-04, female 10.9% 2025 down 15.6% 14th
Population ages 00-04, male 11.2% 2025 down 15.0% 14th
Population ages 05-09, female 10.8% 2025 down 6.6% 15th
Population ages 05-09, male 11.0% 2025 down 6.3% 14th
Population ages 15-19, female 9.6% 2025 up 0.2% 14th
Population ages 15-19, male 9.8% 2025 up 0.3% 14th
Population ages 10-14, female 10.6% 2025 up 3.5% 13th
Population ages 10-14, male 10.9% 2025 up 3.8% 14th
Population ages 20-24, female 8.4% 2025 down 7.1% 18th
Population ages 20-24, male 8.6% 2025 down 7.4% 17th
Population ages 25-29, female 7.7% 2025 down 10.6% 22nd
Population ages 25-29, male 7.8% 2025 down 10.0% 23rd
Population ages 30-34, female 7.3% 2025 down 5.3% 17th
Population ages 30-34, male 7.4% 2025 down 4.0% 23rd
Population ages 35-39, female 6.9% 2025 up 8.7% 27th
Population ages 35-39, male 6.9% 2025 up 9.2% 30th
Population ages 40-44, female 6.2% 2025 up 15.6% 34th
Population ages 40-44, male 6.2% 2025 up 15.4% 34th
Population ages 45-49, female 5.1% 2025 up 11.4% 34th
Population ages 45-49, male 5.1% 2025 up 12.3% 35th
Population ages 50-54, female 4.3% 2025 up 9.3% 35th
Population ages 50-54, male 4.2% 2025 up 11.0% 35th
Population ages 55-59, female 3.6% 2025 up 14.1% 33rd
Population ages 55-59, male 3.5% 2025 up 14.8% 35th
Population ages 60-64, female 3.0% 2025 up 20.0% 33rd
Population ages 60-64, male 2.8% 2025 up 19.4% 33rd
Population ages 65-69, female 2.3% 2025 up 26.4% 33rd
Population ages 65-69, male 2.0% 2025 up 25.3% 33rd
Population ages 70-74, female 1.6% 2025 up 28.8% 32nd
Population ages 70-74, male 1.4% 2025 up 27.3% 32nd
Population ages 75-79, female 1.0% 2025 up 19.3% 33rd
Population ages 75-79, male 0.8% 2025 up 17.3% 32nd
Population ages 80 and above, female 0.8% 2025 up 16.6% 34th
Population ages 80 and above, male 0.6% 2025 up 10.9% 33rd
Population ages 00-04, female 40.58 million 2025 up 0.6% 23rd
Population ages 00-04, male 42.51 million 2025 up 0.4% 23rd